These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6341597)

  • 21. Immunological properties of the lipopolysaccharide-protein complex of Coxiella burnetii.
    Kazár J; Schramek S; Brezina R
    Acta Virol; 1978 Jul; 22(4):309-15. PubMed ID: 29470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technical problems arising from the use of the immunoblot for determination of the reactivity of natural antibodies with different lipopolysaccharides (LPS).
    Schoenherr G; Roggenbuck D; Seifert M; Jahn S; Porstmann T
    J Immunol Methods; 1996 Apr; 190(2):185-8. PubMed ID: 8621953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and quantitative determination of antibodies against major outer mambranes proteins of Escherichia coli O26 K60.
    Hofstra H; Dankert J
    J Gen Microbiol; 1980 Apr; 117(2):437-47. PubMed ID: 6775043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of antibodies against bacterial lipopolysaccharides and lipid A by immunoblotting.
    Fink PC; Bokelmann G; Haeckel R
    Prog Clin Biol Res; 1989; 308():1043-51. PubMed ID: 2780685
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of anti-ECA antibodies in rabbit antiserum against rough Yersinia enterocolitica O:3.
    Rabsztyn K; Kasperkiewicz K; Duda KA; Li CM; Lukasik M; Radziejewska-Lebrecht J; Skurnik M
    Biochemistry (Mosc); 2011 Jul; 76(7):832-9. PubMed ID: 21999545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of lipopolysaccharide activation of 7OZ/3 cells by anti-lipopolysaccharide antibodies.
    Kirkland TN; Ziegler EJ; Tobias P; Ward DC; Michalek SM; McGhee JR; Macher I; Urayama K; Appelmelk BJ
    J Immunol; 1988 Nov; 141(9):3208-13. PubMed ID: 3262686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nontoxic, idiotope vaccine against gram-negative bacterial infections.
    Su S; Ward MM; Apicella MA; Ward RE
    J Immunol; 1992 Jan; 148(1):234-8. PubMed ID: 1727868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemolytic properties of bacteria from the genus Acinetobacter].
    Fleischer M; Przondo-Mordarska A
    Med Dosw Mikrobiol; 1993; 45(3):311-5. PubMed ID: 8189803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunogenic complex of alkali-treated lipid A and methylated bovine serum albumin.
    Eskenazy M; Tekelieva R; Ivanova R
    Ann Inst Pasteur Immunol; 1987; 138(5):687-92. PubMed ID: 3440059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysaccharides from different families of gram-negative bacteria.
    Brade H; Galanos C
    Infect Immun; 1983 Oct; 42(1):250-6. PubMed ID: 6194116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of two different antibody specificities recognizing distinct antigenic determinants in free lipid A of Escherichia coli.
    Brade L; Brade H
    Infect Immun; 1985 Jun; 48(3):776-81. PubMed ID: 2581900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on natural antibodies to gram-negative bacteria.
    MICHAEL JG; WHITBY JL; LANDY M
    J Exp Med; 1962 Jan; 115(1):131-46. PubMed ID: 14473316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of plasmid RP1 on phase changes in inner and outer membranes and lipopolysaccharide from Acinetobacter calcoaceticus: a Fourier transform infrared study.
    Loeffelholz MJ; Rana F; Modrzakowski MC; Blazyk J
    Biochemistry; 1987 Oct; 26(21):6644-8. PubMed ID: 3427032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endotoxaemia and acute pancreatitis: correlation between the severity of the disease and the anti-enterobacterial common antigen antibody titre.
    Kivilaakso E; Valtonen VV; Malkamäki M; Palmu A; Schröder T; Nikki P; Mäkelä PH; Lempinen M
    Gut; 1984 Oct; 25(10):1065-70. PubMed ID: 6479681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical state and biological activity of lipopolysaccharides. Toxicity and immunogenicity of the lipid A component.
    Galanos C
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):214-29. PubMed ID: 126555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The isolation of cell surface mutants of Acinetobacter calcoaceticus RAG-1.
    Bayer EA; Rosenberg E; Gutnick D
    J Gen Microbiol; 1981 Dec; 127(2):295-300. PubMed ID: 6806434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental study of the general serology of immunopathological processes].
    Ioffe VI; Kopytovskaia LP; Savel'vol'f GB; Bogdanova MA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Feb; (2):71-7. PubMed ID: 1124621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on Acinetobacter calcoaceticus. Protective effects of antiserum and vaccine to infection].
    Obana Y; Nishino T; Tanino T
    Kansenshogaku Zasshi; 1982 Sep; 56(9):762-8. PubMed ID: 6816861
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of the slime from Acinetobacter calcoaceticus on the function of phagocytic cells].
    Obana Y; Nishino T; Tanino T
    Kansenshogaku Zasshi; 1987 Sep; 61(9):1059-63. PubMed ID: 3127500
    [No Abstract]   [Full Text] [Related]  

  • 40. Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.
    Grandjean C; Boutonnier A; Dassy B; Fournier JM; Mulard LA
    Glycoconj J; 2009 Jan; 26(1):41-55. PubMed ID: 18648931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.